CN111056939B - 一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 - Google Patents
一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 Download PDFInfo
- Publication number
- CN111056939B CN111056939B CN201910983262.7A CN201910983262A CN111056939B CN 111056939 B CN111056939 B CN 111056939B CN 201910983262 A CN201910983262 A CN 201910983262A CN 111056939 B CN111056939 B CN 111056939B
- Authority
- CN
- China
- Prior art keywords
- solvent
- formula
- preparation
- mixture
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- YHFYRVZIONNYSM-CRCLSJGQSA-N (1r,3s)-3-aminocyclopentan-1-ol Chemical compound N[C@H]1CC[C@@H](O)C1 YHFYRVZIONNYSM-CRCLSJGQSA-N 0.000 title abstract description 36
- 239000002904 solvent Substances 0.000 claims abstract description 80
- 150000001875 compounds Chemical class 0.000 claims abstract description 77
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229910001868 water Inorganic materials 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000012046 mixed solvent Substances 0.000 claims abstract description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 32
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 238000001953 recrystallisation Methods 0.000 claims description 14
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 13
- 150000002576 ketones Chemical group 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 9
- 229960002009 naproxen Drugs 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 238000005755 formation reaction Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- 230000003287 optical effect Effects 0.000 abstract description 3
- 125000000468 ketone group Chemical group 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 17
- 238000003756 stirring Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 230000006837 decompression Effects 0.000 description 8
- SOLUWJRYJLAZCX-LYOVBCGYSA-N bictegravir Chemical compound C([C@H]1O[C@@H]2CC[C@@H](C2)N1C(=O)C1=C(C2=O)O)N1C=C2C(=O)NCC1=C(F)C=C(F)C=C1F SOLUWJRYJLAZCX-LYOVBCGYSA-N 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000012065 filter cake Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229950004159 bictegravir Drugs 0.000 description 6
- LDEKQSIMHVQZJK-CAQYMETFSA-N tenofovir alafenamide Chemical compound O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1 LDEKQSIMHVQZJK-CAQYMETFSA-N 0.000 description 6
- 229960004946 tenofovir alafenamide Drugs 0.000 description 6
- 239000012043 crude product Substances 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000001212 derivatisation Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- -1 respectively Chemical compound 0.000 description 3
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 2
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229940126656 GS-4224 Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229940124524 integrase inhibitor Drugs 0.000 description 2
- 239000002850 integrase inhibitor Substances 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 229940011051 isopropyl acetate Drugs 0.000 description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- YHFYRVZIONNYSM-UHNVWZDZSA-N (1s,3r)-3-aminocyclopentan-1-ol Chemical compound N[C@@H]1CC[C@H](O)C1 YHFYRVZIONNYSM-UHNVWZDZSA-N 0.000 description 1
- NEPLBHLFDJOJGP-BYPYZUCNSA-N (2s)-2-(5-fluoro-2,4-dinitroanilino)propanamide Chemical compound NC(=O)[C@H](C)NC1=CC(F)=C([N+]([O-])=O)C=C1[N+]([O-])=O NEPLBHLFDJOJGP-BYPYZUCNSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- UGWQMIXVUBLMAH-IVVFTGHFSA-N [(1s,4r)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 UGWQMIXVUBLMAH-IVVFTGHFSA-N 0.000 description 1
- 229940030360 abacavir / lamivudine Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229960000366 emtricitabine Drugs 0.000 description 1
- 229940083713 emtricitabine / tenofovir alafenamide Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910983262.7A CN111056939B (zh) | 2019-10-16 | 2019-10-16 | 一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910983262.7A CN111056939B (zh) | 2019-10-16 | 2019-10-16 | 一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111056939A CN111056939A (zh) | 2020-04-24 |
CN111056939B true CN111056939B (zh) | 2022-08-05 |
Family
ID=70297524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910983262.7A Active CN111056939B (zh) | 2019-10-16 | 2019-10-16 | 一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111056939B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111733195B (zh) * | 2020-07-14 | 2023-06-30 | 宁波酶赛生物工程有限公司 | 制备(1r,3s)-3-氨基环戊醇的方法、整合酶抑制剂、应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102633657A (zh) * | 2012-03-30 | 2012-08-15 | 兰州中泰和生物科技有限公司 | 一种顺式3-氨基-环戊醇盐酸盐的制备方法 |
WO2015195656A2 (en) * | 2014-06-20 | 2015-12-23 | Gilead Sciences ,Inc. | Synthesis of polycyclic-carbamoylpyridone compounds |
CN109988073A (zh) * | 2018-01-03 | 2019-07-09 | 上海迪赛诺药业股份有限公司 | 手性拆分制备单一构型3-氨基环戊醇的方法 |
-
2019
- 2019-10-16 CN CN201910983262.7A patent/CN111056939B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102633657A (zh) * | 2012-03-30 | 2012-08-15 | 兰州中泰和生物科技有限公司 | 一种顺式3-氨基-环戊醇盐酸盐的制备方法 |
WO2015195656A2 (en) * | 2014-06-20 | 2015-12-23 | Gilead Sciences ,Inc. | Synthesis of polycyclic-carbamoylpyridone compounds |
CN109988073A (zh) * | 2018-01-03 | 2019-07-09 | 上海迪赛诺药业股份有限公司 | 手性拆分制备单一构型3-氨基环戊醇的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111056939A (zh) | 2020-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2382777C2 (ru) | Способ получения эзомепразола и его солей | |
CN102985416A (zh) | 制备凝血酶特异性抑制剂的方法 | |
CN111056939B (zh) | 一种(1r,3s)-3-氨基环戊醇及其中间体的制备方法 | |
WO2012004391A1 (en) | Process for the preparation of flupirtine maleate | |
CN108997198B (zh) | 一种盐酸替罗非班的制备方法 | |
CN114249711A (zh) | 一种拆分制备尼古丁的方法 | |
CN110467580B (zh) | 雷西纳德轴手性对映体的拆分方法 | |
CN112679498A (zh) | 磺酸季铵盐化合物及其制备方法和用途 | |
CN107935866B (zh) | 盐酸达泊西汀杂质的制备方法 | |
CN108239091B (zh) | 1-环己基-2-(5H-咪唑[5,1-a]异吲哚)乙基-1-酮的拆分 | |
CN110804022B (zh) | 一种右丙亚胺的制备方法 | |
CN115850169A (zh) | 苯磺顺阿曲库铵杂质及其中间体的制备方法 | |
JP3981520B2 (ja) | 有機化合物の分離方法 | |
JP5406194B2 (ja) | R−ゴシポールl−フェニルアラニノールジエナミンを調製するための方法 | |
WO2005118524A1 (fr) | Procede de preparation de derives de [(s)-(-)-alpha-methylamino phenylacetone]2 (2r,3r)-acide tartrique | |
CN113354581A (zh) | 手性氯喹及其磷酸盐的制备方法及其应用 | |
JP5664870B2 (ja) | 3環性ベンゾピラン化合物の新規な結晶形態及びその製造方法 | |
CN111793017A (zh) | 一种内酰胺化合物的制备方法 | |
CN113121456B (zh) | 一种阿昔莫司尿素共晶 | |
CN111187255B (zh) | 右旋艾普拉唑钾盐的制备方法和右旋艾普拉唑的制备方法 | |
JP2022074008A (ja) | トレプロスチニル一水和物結晶およびその製造方法 | |
CN110835319B (zh) | 一种贝那普利中间体和贝那普利盐酸盐的合成方法 | |
JP6433809B2 (ja) | 1−(3−ヒドロキシメチルピリジル−2−)−2−フェニル−4−メチルピペラジンの製造方法 | |
CN112898234A (zh) | 一种盐酸兰地洛尔中间体的制备方法 | |
CN116199596A (zh) | 一种特布他林代谢物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200240 Applicant after: Ecolab Biotechnology (Shanghai) Co.,Ltd. Address before: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200240 Applicant before: ABIOCHEM BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee after: Yikelai Biotechnology (Group) Co.,Ltd. Address before: Room 3114, building B, 555 Dongchuan Road, Minhang District, Shanghai 200240 Patentee before: Ecolab Biotechnology (Shanghai) Co.,Ltd. |